Discovery of novel N4-alkylcytidines as promising antimicrobial agents

Eur J Med Chem. 2021 Apr 5:215:113212. doi: 10.1016/j.ejmech.2021.113212. Epub 2021 Feb 1.

Abstract

The emergence of drug-resistant strains of pathogenic microorganisms necessitates the creation of new drugs. In order to find new compounds that effectively inhibit the growth of pathogenic bacteria and fungi, we synthesized a set of N4-derivatives of cytidine, 2'-deoxycytidine and 5-metyl-2'-deoxycytidine bearing extended N4-alkyl and N4-phenylalkyl groups. The derivatives demonstrate activity against a number of Gram-positive bacteria, including Mycobacterium smegmatis (MIC = 24-200 μM) and Staphylococcus aureus (MIC = 50-200 μM), comparable with the activities of some antibiotics in medical use. The most promising compound appeared to be N4-dodecyl-5-metyl-2'-deoxycytidine 4h with activities of 24 and 48 μM against M. smegmatis and S. aureus, respectively, and high inhibitory activity of 0.5 mM against filamentous fungi that can, among other things, damage works of art, such as tempera painting. Noteworthy, some of other synthesized compounds are active against fungal growth with the inhibitory concentration in the range of 0.5-3 mM.

Keywords: Antibacterial; Antifungal; Cytidine; Nucleoside; Preservation.

MeSH terms

  • A549 Cells
  • Animals
  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / toxicity
  • Antifungal Agents / chemical synthesis
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / toxicity
  • Bacteria / drug effects
  • Cytidine / analogs & derivatives*
  • Cytidine / pharmacology*
  • Cytidine / toxicity
  • Drug Discovery
  • Fungi / drug effects
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Cytidine